Literature DB >> 22627483

Cytomegalovirus and eye.

R Agrawal.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22627483      PMCID： PMC3420039          DOI： 10.1038/eye.2012.103

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  Juxtapapillary cytomegalovirus retinitis with optic neuritis.

Authors:  Alexander S Ioannidis; James Bacon; Peggy Frith
Journal:  J Neuroophthalmol       Date:  2008-06       Impact factor: 3.042

2.  Immune ring formation associated with cytomegalovirus endotheliitis.

Authors:  Soon-Phaik Chee; Aliza Jap
Journal:  Am J Ophthalmol       Date:  2011-06-14       Impact factor: 5.258

Review 3.  Cytomegalovirus optic neuritis.

Authors:  A M Mansour
Journal:  Curr Opin Ophthalmol       Date:  1997-06       Impact factor: 3.761

Review 4.  Viral anterior uveitis.

Authors:  Aliza Jap; Soon-Phaik Chee
Journal:  Curr Opin Ophthalmol       Date:  2011-11       Impact factor: 3.761

5.  Cytomegalovirus and the eye.

Authors:  A Carmichael
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

6.  Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients.

Authors:  A Jayaprakash Patil; Ashish Sharma; M Cristina Kenney; Baruch D Kuppermann
Journal:  Clin Ophthalmol       Date:  2010-03-04
  6 in total
  2 in total

Review 1.  Cytomegalovirus-related uncontrolled glaucoma in an immunocompetent patient: a case report and systematic review.

Authors:  Lei Xi; Liang Zhang; Wenlei Fei
Journal:  BMC Ophthalmol       Date:  2018-09-29       Impact factor: 2.209

2.  OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism.

Authors:  Xiaofei E; Paul Meraner; Ping Lu; Jill M Perreira; Aaron M Aker; William M McDougall; Ronghua Zhuge; Gary C Chan; Rachel M Gerstein; Patrizia Caposio; Andrew D Yurochko; Abraham L Brass; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-20       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.